Clarity Medical: Co-CEO Chris Hui to Step Down in April 2026, Remain Senior Advisor Until June 2026

Bulletin Express05-15

Clarity Medical Group Holding Limited announced the resignation of Mr. Hui Yung Chris from his roles as Co-Chief Executive Officer and authorised process agent, effective 30 April 2026. The departure, made under Rule 13.51(2) of the Hong Kong Listing Rules, is attributed to Mr. Hui’s intention to devote more time to personal and business commitments.

Following his resignation, Mr. Hui will continue to support the company as a senior advisor until 30 June 2026. He confirmed no disagreements with the board and stated that no additional matters require shareholder attention.

The board expressed appreciation for Mr. Hui’s contributions during his tenure. Current executive leadership will remain under Executive Director and CEO Mr. Jiang Bo. The board composition at the announcement date comprises one executive director, four non-executive directors and four independent non-executive directors.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment